What does business segments — sublease income mean?

Revenue generated from leasing out excess office or laboratory space to third parties. This serves as a non-core income stream that helps offset the fixed costs of real estate commitments.

Dogwood Therapeutics DWTX Business Segments — Sublease Income

Similar metrics at other companies

CNVSSublease Income

$0-100%

CHE

CHESublease Income

$31K-13.9%

USCBSublease Income

$21.25K+3.7%

TBBKSublease Income

$50.75K-50.0%

JAK

JAKKSublease Income

$700K+75.0%

WTWSublease Income

$10M+66.7%

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:SubleaseIncome.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's business segments — sublease income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's business segments — sublease income?: Dogwood Therapeutics (DWTX) reported business segments — sublease income of $19.46K in Q1 2026.
What does business segments — sublease income mean?: Revenue generated from leasing out excess office or laboratory space to third parties. This serves as a non-core income stream that helps offset the fixed costs of real estate commitments.